Membrane Proteins < Membrane Transport Proteins < Memory

Facettes :

List of bibliographic references indexed by Membrane Transport Proteins

Number of relevant bibliographic references: 47.
[0-20] [0 - 20][0 - 47][20-40]

Ident.	Authors (with country if any)	Title
000727 (2013)	Maja Kojovic [Royaume-Uni] ; Isabel Pareés ; Tania Lampreia ; Karolina Pienczk-Reclawowicz ; Georgia Xiromerisiou ; Ignacio Rubio-Agusti ; Milica Kramberger ; Miryam Carecchio ; Anas M. Alazami ; Francesco Brancati ; Jaroslaw Slawek ; Zvezdan Pirtosek ; Enza Maria Valente ; Fowzan S. Alkuraya ; Mark J. Edwards ; Kailash P. Bhatia	The syndrome of deafness-dystonia: clinical and genetic heterogeneity.
000822 (2013)	Laura Cif [France] ; Victoria Gonzalez ; Sara Garcia-Ptacek ; Syril James ; Julien Boetto ; Anne Seychelles ; Thomas Roujeau ; Ana Maria Moura De Ribeiro ; Martine Sillon ; Michel Mondain ; Philippe Coubes	Progressive dystonia in Mohr-Tranebjaerg syndrome with cochlear implant and deep brain stimulation.
000B76 (2012)	Ainhi D. Ha [Australie] ; Kaitlyn L. Parratt ; Nanna D. Rendtorff ; Marianne Lodahl ; Karl Ng ; Dominic B. Rowe ; Carolyn M. Sue ; Michael W. Hayes ; Lisbeth Tranebjaerg ; Victor S C. Fung	The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome.
000C34 (2012)	Mercedes Serrano [Espagne] ; M Nica Rebollo ; Christel Depienne ; Agnès Rastetter ; Emilio Fernández-Álvarez ; Jordi Muchart ; Loreto Martorell ; Rafael Artuch ; José A. Obeso ; Belén Pérez-Due As	Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.
002F87 (2007)	Hee T. Kim [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Jess Tyson [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Maria Bitner-Glindzicz [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]	Blepharospasm and limb dystonia caused by Mohr‐Tranebjaerg syndrome with a novel splice‐site mutation in the deafness/dystonia peptide gene
003709 (2005)	Paul Morrish [Royaume-Uni]	The meaning of negative DAT SPECT and F‐Dopa PET scans in patients with clinical Parkinson's disease
003835 (2005)	Anjum Misbahuddin [Royaume-Uni] ; Mark R. Placzek [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni] ; Steve Gschmeissner [Royaume-Uni] ; Giampietro Schiavo [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Thomas T. Warner [Royaume-Uni]	Mutant torsinA, which causes early‐onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH‐SY5Y cells
003948 (2005)	Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]	Dopaminergic innervation of the human striatum in Parkinson's disease
003B82 (2004)	Sarah Furtado [Canada] ; Haydeh Payami [États-Unis] ; Paul J. Lockhart [États-Unis] ; Melissa Hanson [États-Unis] ; John G. Nutt [États-Unis] ; Andrew A. Singleton [États-Unis] ; Amanda Singleton [États-Unis] ; Jamel Bower [États-Unis] ; Ryan J. Utti [États-Unis] ; Thomas D. Bird [États-Unis] ; Raul De La Fuente-Fernandez [Canada] ; Yoshio Tsuboi [États-Unis] ; Mary L. Klimek [Canada] ; Oksana Suchowersky [Canada] ; John Hardy [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; A. Jon Stoessl [Canada]	Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2)
003B87 (2004)	Rainer Linke [Allemagne] ; Ilonka Eisensehr [Allemagne] ; Thomas-Christian Wetter [Allemagne] ; Franz-Josef Gildehaus [Allemagne] ; Gabriele Pöpperl [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Soheyl Noachtar [Allemagne] ; Klaus Tatsch [Allemagne]	Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson's disease?
003C63 (2004)	Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
003C91 (2004)	Ana M. Catafau [Espagne] ; Eduardo Tolosa [Espagne]	Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes
003D30 (2004)	William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova [États-Unis] ; Abdulah Sherzai [États-Unis] ; Antonella Favit [États-Unis] ; M. M. Mouradian [États-Unis] ; Thomas N. Chase [États-Unis]	Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease
003D33 (2004)	Stefan H. Kreisel [Allemagne] ; Johannes Binder [Allemagne] ; Johannes C. Wöhrle [Allemagne] ; Joachim K. Krauss [Allemagne] ; Sabine Hofmann [Allemagne] ; Matthias F. Bauer [Allemagne] ; Michael G. Hennerici [Allemagne] ; Hansjörg B Zner [Allemagne]	Dystonia in the Mohr–Tranebjaerg syndrome responds to GABAergic substances
003E09 (2004)	Sebastian Paus [Allemagne] ; Gert Seeger [Allemagne] ; Hans M. Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Mahha El-Faddagh [Allemagne] ; Markus M. Nöthen [Belgique] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]	Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease
003E30 (2004)	Sylvia M. Boesch [Autriche] ; Eveline Donnemiller [Autriche] ; Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]	Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study
003E89 (2003)	Stephen J. Kish [Canada]	What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
003F10 (2003)	Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]	Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
003F52 (2003)	Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni]	Role of dopamine transporter imaging in routine clinical practice
003F53 (2003)	Werner Poewe [Autriche] ; Christoph Scherfler [Autriche]	Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice
003F54 (2003)	Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne]	Role of dopamine transporter SPECT for the practitioner and the general neurologist

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Membrane Transport Proteins" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Membrane Transport Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Membrane Transport Proteins
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024